Clinical characteristics, management and in-hospital outcomes of patients with acute coronary syndrome - Observations from the Taiwan ACS full spectrum registry

Acta Cardiologica Sinica

Volumn 27, Issue 3, 2011, Pages 135-144

  Shyu, Kou Gi ^a   Wu, Chiung Jen ^b,c   Mar, Guang Yuan ^d   Hou, Charles Jia Yin ^e   Li, Ai Hsien ^f   Wen, Ming Shien ^b,c   Lai, Wen Ter ^g   Lin, Shing Jong ^h   Kuo, Chi Tai ^b,c   Hwang, Juey Jen ⁱ   Chiang, Fu Tien ⁱ  

^a SHIN KONG WU HO SU MEMORIAL HOSPITAL   (Taiwan)

^b CHANG GUNG UNIVERSITY COLLEGE OF MEDICINE   (Taiwan)

^c CHANG GUNG MEMORIAL HOSPITAL   (Taiwan)

^d KAOHSIUNG VETERANS GENERAL HOSPITAL   (Taiwan)

^e MACKAY MEMORIAL HOSPITAL   (Taiwan)

^f FAR EASTERN MEMORIAL HOSPITAL   (Taiwan)

^g KAOHSIUNG MEDICAL UNIVERSITY HOSPITAL   (Taiwan)

^h TAIPEI VETERANS GENERAL HOSPITAL   (Taiwan)

ⁱ NATIONAL TAIWAN UNIVERSITY HOSPITAL   (Taiwan)

Author keywords

Acute coronary syndrome; Antiplatelet therapy; Door to balloon; Door to needle; Full spectrum registry; Taiwan

Indexed keywords

ACETYLSALICYLIC ACID; BETA ADRENERGIC RECEPTOR BLOCKING AGENT; CLOPIDOGREL; DIPEPTIDYL CARBOXYPEPTIDASE INHIBITOR; GLYCOPROTEIN P INHIBITOR; HEPARIN; STATINE;

ACUTE CORONARY SYNDROME; ACUTE KIDNEY FAILURE; ADULT; AGED; ARTICLE; BLEEDING; CARDIOGENIC SHOCK; CONTROLLED STUDY; CORONARY ARTERY BYPASS GRAFT; DISEASE REGISTRY; FEMALE; HEART ATRIUM FIBRILLATION; HEART VENTRICLE ARRHYTHMIA; HOSPITAL ADMISSION; HOSPITAL DISCHARGE; HOSPITAL PATIENT; HOSPITALIZATION; HUMAN; MAJOR CLINICAL STUDY; MALE; MORTALITY; MULTICENTER STUDY; OBSERVATIONAL STUDY; PERCUTANEOUS CORONARY INTERVENTION; PROSPECTIVE STUDY; RENIN ANGIOTENSIN ALDOSTERONE SYSTEM; ST SEGMENT ELEVATION MYOCARDIAL INFARCTION; STROKE; TAIWAN;

EID: 84863014598     PISSN: 10116842     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (29)

1. O'Kelly B, Massie B, Tubau J, et al. Coronary morbidity and mortality, pre-existing silent coronary artery disease, and mild hypertension. Ann Intern Med 1989;110:1017-26. (Pubitemid 19156703)
2. Bakhai A. The burden of coronary, cerebrovascular and peripheral arterial disease. Pharmacoeconomics 2004;22:11-8. (Pubitemid 40066089)
3. Taiwan Department of Health. Statistics data. Statistical analysis of 2009 mortality data. Press conference on 2009 mortality data. Accessed on January 19, 2011 at http://www.doh.gov.tw.
4. Braunwald E, Antman E, Beasley J, et al. ACC/AHA guideline update for the management of patients with unstable angina and non-ST-segment elevation myocardial infarction - 2002: summary article: a report of the American College of Cardiology/American Heart Association Task Force on Practice Guidelines (Committee on the Management of Patients With Unstable Angina). Circulation 2002;106:1893-900.
5. Antman E, Anbe D, Armstrong P, et al. ACC/AHA guidelines for the management of patients with ST-Elevation myocardial infarction: a report of the American College of Cardiology/American Heart Association Task Force on Practice Guidelines (Committee to Revise the 1999 Guidelines for the Management of Patients with Acute Myocardial Infarction). Circulation 2004;110:e82-292.
6. Bertrand M, Simons M, Fox K, et al. Management of acute coronary syndromes in patients presenting without persistent ST-segment elevation. Eur Heart J 2002;23:1809-40.
7. Andersen J, Adams C, Antman E, et al. ACC/AHA 2007 guidelines for the management of patients with unstable angina/non-ST-elevation myocardial infarction: a report of the American College of Cardiology/American Heart Association Task Force on Practice Guidelines (Writing Committee to Revise the 2002 Guidelines for the Management of Patients with Unstable Angina/Non-ST-Elevation Myocardial Infarction). Circulation 2007;116:e148-304.
8. Antman E, Hand M, Armstrong P, et al. 2007 focused update of the ACC/AHA 2004 guidelines for the management of patients with ST-elevation myocardial infarction: a report of the American College of Cardiology/American Heart Association Task Force on Practice Guidelines. Circulation 2008;117:296-329.
9. Kushner F, Hand M, Smith S Jr, et al. 2009 focused updates: ACC/AHA guidelines for the management of patients with ST-elevation myocardial infarction (updating the 2004 guideline and 2007 focused update) and ACC/AHA/SCAI guidelines on percutaneous coronary intervention (updating the 2005 guideline and 2007 focused update) a report of the American College of Cardiology Foundation/American Heart Association Task Force on Practice Guidelines. Circulation 2009;120:2271-306
10. Bassand JP, HammCW, Ardissino D. Guidelines for the diagnosis and treatment of non-ST-segment elevation acute coronary syndromes. Eur Heart J 2007;28:1598-660.
11. Van deWerf F, Bax J, Betriu A. Management of acute myocardial infarction in patients presenting with persistent ST-segment elevation. Eur Heart J 2008;29:2909-45.
12. Rapezzi C, Biagini E, Branzi A. Guidelines for the diagnosis and treatment of non-ST-segment elevation acute coronary syndromes: the task force for the diagnosis and treatment of non-ST-segment elevation acute coronary syndromes of the European Society of Cardiology. Eur Heart J 2008;29:277-8.
13. Bottorff M, Nutescu E, Spinler S. Antiplatelet therapy in patients with unstable angina and non-ST-segment-elevation myocardial infarction: findings from the CRUSADE national quality improvement initiative. Pharmacotherapy 2007;27:1145-62. (Pubitemid 47179791)
14. Peterson E, Roe M, Mulgund J, DeLong E. Association between hospital process performance and outcomes among patients with acute coronary syndromes. JAMA 2006;295:1912-20.
15. Budaj A, Brieger D, Steg G, et al. Global patterns of use of antithrombotic and antiplatelet therapies in patients with acute coronary syndromes: insights from the Global Registry of Acute Coronary Events (GRACE). Am Heart J 2003;146:999-1006. (Pubitemid 37500773)
16. Chew D, Amerena J, Coverdale S, et al. Invasive management and late clinical outcomes in contemporary Australian management of acute coronary syndromes: observations from the ACACIA registry. Med J Aust 2008;188:691-7.
17. Cheng C, Chen C, Kuan P, et al. The causes and outcomes of inadequate implementation of existing guidelines for antiplatelet treatment in patients with acute coronary syndrome: the experience from Taiwan Acute Coronary Syndrome Descriptive Registry (T-ACCORD Registry). Clin Cardiol 2010;33:E40-8.
18. International Epidemiological Association guidelines. Accessed on 28 January, 2011 at http://www.ieaweb.org/index.php?option=com-content&view= article&id=15%3Agood-epidemiological-practice-gep&catid= 20%3Agood-epidemiological-practice-gep&Itemid=43&limitstart=1.
19. Steg PG, Goldberg RJ, Gore JM, et al. Baseline characteristics, management practice, and in-hospital outcomes of patients hospitalized with acute coronary syndrome in the Global Registry of Acute Coronary Events (GRACE). Am J Cardiol 2002;90:358-63.
20. Yan AT, Tan M, Fitchelt D, et al. One-year outcome of patients after acute coronary syndromes (from the Canadian Acute Coronary Syndrome Registry). Am J Cardiol 2004;94:25-9. (Pubitemid 38813448)
21. Tsai JP, Chen YC, Hung CL, et al. Reduced inhospital mortality in patients with acute myocardial infarction after practice of percutaneous coronary intervention at a remote hospital in Taiwan. Acta Cardiol Sin 2011;27:86-93.
22. Yusuf S, Zhao F, Mehta S, et al. Effects of clopidogrel in addition to aspirin in patients with acute coronary syndromes without ST-segment elevation. N Engl J Med 2001;345:494-502. (Pubitemid 32758501)
23. Mehta S, Yusuf S, Peters R, et al. Effects of pretreatment with clopidogrel and aspirin followed by long-term therapy in patients undergoing percutaneous coronary intervention: the PCI-CURE study. Lancet 2001;358:527-33. (Pubitemid 32772726)
24. Sabatine M, Cannon C, Gibson C, et al. Addition of clopidogrel to aspirin and fibrinolytic therapy for myocardial infarction with ST-segment elevation. N Engl J Med 2005;352:1179-89. (Pubitemid 40397259)
25. Chen Z, Jiang L, Chen Y, et al. Addition of clopidogrel to aspirin in 45,852 patients with acute myocardial infarction: randomised placebo-controlled trial. Lancet 2005;366:1607-21. (Pubitemid 41552416)
26. Bhatt D, Steg P, Ohman E, et al. International prevalence, recognition, and treatment of cardiovascular risk factors in outpatients with atherothrombosis. JAMA 2006;295:180-9. (Pubitemid 43076437)
27. Patrono C, Bachmann F, Baigent C, et al. Expert consensus document on the use of antiplatelet agents. The task force on the use of antiplatelet agents in patients with atherosclerotic cardiovascular disease of the European society of cardiology. Eur Heart J 2004;25:166-81. (Pubitemid 38112156)
28. The PURSUIT Trial Investigators. Inhibition of platelet glycoprotein IIb/IIIa with eptifibatide in patients with acute coronary syndromes. Platelet glycoprotein IIb/IIIa in unstable angina: receptor suppression using integrilin therapy trial. N Engl J Med 1998;339:436-43.
29. Ferguson J, Califf R, Antman E, et al. Enoxaparin vs unfractionated heparin in high-risk patients with non-ST-segment elevation acute coronary syndromes managed with an intended early invasive strategy: primary results of the SYNERGY randomized trial. JAMA 2004;292:45-54.